Clinical Trials in Houston

Showing 3641-3660 of 15,366 trials

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

NCT00788671

This phase II trial studies how well levonorgestrel-releasing intrauterine system works in treating patients with complex atypical hyperplasia or grade I endometrial cancer. High levels of estrogen can cause the growth of endometrial cancer cells. Progesterone can help balance the amount of estrogen present. Hormone therapy using levonorgestrel, a type of progesterone, may fight endometrial cancer by helping regulate hormone levels.

Atypical Endometrial HyperplasiaStage I Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7+2 more

M.D. Anderson Cancer Center69 participantsStarted Nov 2008

Houston, Texas, United States • Houston, Texas, United States • Houston, Texas, United States +4 more locations

Active Not Recruiting< 1 mile

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

NCT03687359

Primary Objectives: * To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable. * To evaluate the time-course of AD and selected atopic comorbidities. Secondary Objectives: * To characterize disease burden and unmet need. * To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching). * To document the real-world effectiveness and safety of treatments.

Dermatitis Atopic

Sanofi1,860 participantsStarted Aug 2019

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Montgomery, Alabama, United States +179 more locations

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Find Trials by Condition in Houston

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

INSPIRE Trial for Abdominal Infections

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Actis Total Hip System 2 Year Follow-up

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Lupus Landmark Study: A Prospective Registry and Biorepository

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours